Roche Maintains Stability – CEO Thomas Schinecker Assures Workforce Levels Will Not Drop
Swiss pharmaceutical giant Roche remains on solid footing with no immediate plans for job reductions, according to recent statements by CEO Thomas Schinecker in a Swiss newspaper interview. While the company's share value has significantly dropped from its peak in April 2022, concerns about potential layoffs amid recent challenges in...